Pacific Edge shares fall after US Medicare coverage decision

Monday 13 January 2025 · 2 outlets · 2 reports · updated Mon 13 Jan 2025, 1:18pm

Dunedin-based cancer diagnostics firm Pacific Edge saw its share price plunge following a decision by US Medicare contractor Novitas to revoke coverage for its flagship test. The company described the analysis as flawed and stated it may appeal the decision or pursue legal action.

How they headlined it

12:20pm1:18pm

1. Otago Daily TimesMon 13 Jan 2025, 12:20pm

   'Flawed analysis': Pacific Edge shares tumble after Medicare decision (opens in new tab)

2. RNZMon 13 Jan 2025, 1:18pm

   Pacific Edge cancer diagnosis firm shares plunge after US decision (opens in new tab)